The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy
<p>Telomerase is expressed in the majority (>85%) of tumours but not in differentiated normal tissue. This enzyme catalyses the elongation of telomeres – a process critical for continued cell proliferation. Telomerase is a potential novel target for molecularly-targeted radiotherapy (mR...
第一著者: | Jackson, M |
---|---|
その他の著者: | Vallis, K |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
2013
|
主題: |
類似資料
-
Selective targeting of homologous recombination deficiency
著者:: Zimmer, J
出版事項: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
著者:: Albukhari, A
出版事項: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
著者:: Albukhari, A
出版事項: (2014) -
Development of models and methods to assess the efficacy of anti-cancer drugs targeted to the mitochondria
著者:: Potter, M
出版事項: (2014) -
Radiopharmaceutical Validation for Clinical Use
著者:: Charles A. Kunos, 等
出版事項: (2021-03-01)